2011-044 – Technology Description
Triple reuptake inhibitors (TRIs) are a relatively new class of antidepressants that impact dopamine, serotonin and norepinephrine neurotransmission. Mayo Clinic researchers, in collaboration with researchers from Virginia Tech, developed a novel TRI (PRC200-SS) with potent transporter binding and efficacy in mouse behavioral models. A large pharmaceutical company... Read More

2010-162 – The application works on the iPod Touch and iPhone platform and will improve access to exposure-based therapy for individuals with anxiety disorders. The application can be used independently as a self-help program or in conjunction with a health professional.
To Access the App through the iTunes Store, click on the link below.
AnxietyCoach App